Tlc Analysis of Analgesic Drugs
Name: Bill Marano
Due Date: 4-1-13
Experiment Title: TLC Analysis of Analgesic Drugs
Purpose: The purpose of this experiment is to identify the brand name of an unknown commercial analgesic product by TLC analysis. Unknown #1 solution was run against standard solutions of individual analgesics. The components of the unknown product were identified by comparing characteristic traits, such as Rf, fluorescence and iodine staining, to those exhibited by the standards. The name of the commercial product was then determined using the reference table, Analgesics & Caffeine in Some Common Preparations.
Reactions:
Procedure: Refer to Pavia, et. al., Introduction to Organic Laboratory Techniques; 4th ed., Thomson Learning, pp. 82-86
Procedure Modifications: In the Initial Preparations steps we used capillary tubes rather than preparing capillary micropipets to spot the plates. We used 5cm x 20cm TLC plates instead of 6cm x 10cm plates; this required a different slide layout. Also, only 4 samples were spotted on each plate rather than 6. We analyzed 1 unknown commercial product on plate two. All standards were spotted twice and the reference samples as well as unknown were spotted six times. In the Preparing the Development Chamber steps we used large developing chambers which we shared with a partner rather than using the 16-oz. wide mouth jars. The Analysis of Commercial Analgesics or Unknowns steps were omitted since we included an unknown on our second plate.
Observations and Data:
Total TLC development time was 50 minutes.
Table 1: TLC Data for Standard Analgesics, Reference Mix & Unknown Components* Standard Substance | Distance Spot Travels (cm) | Distance Solvent Front Travels (cm) | Fluorescence? | I2 Staining Appearance | Acetaminophen | 48 | 150 | No | Dark Yellow | Aspirin | 86 | 150 | No | Not Significant | Caffeine | 14 | 150 | No | Not Significant | Ibuprofen | 92 | 148 | No | Not Significant | Salicylamide | 81 | 148 | Yes |
Due Date: 4-1-13
Experiment Title: TLC Analysis of Analgesic Drugs
Purpose: The purpose of this experiment is to identify the brand name of an unknown commercial analgesic product by TLC analysis. Unknown #1 solution was run against standard solutions of individual analgesics. The components of the unknown product were identified by comparing characteristic traits, such as Rf, fluorescence and iodine staining, to those exhibited by the standards. The name of the commercial product was then determined using the reference table, Analgesics & Caffeine in Some Common Preparations.
Reactions:
Procedure: Refer to Pavia, et. al., Introduction to Organic Laboratory Techniques; 4th ed., Thomson Learning, pp. 82-86
Procedure Modifications: In the Initial Preparations steps we used capillary tubes rather than preparing capillary micropipets to spot the plates. We used 5cm x 20cm TLC plates instead of 6cm x 10cm plates; this required a different slide layout. Also, only 4 samples were spotted on each plate rather than 6. We analyzed 1 unknown commercial product on plate two. All standards were spotted twice and the reference samples as well as unknown were spotted six times. In the Preparing the Development Chamber steps we used large developing chambers which we shared with a partner rather than using the 16-oz. wide mouth jars. The Analysis of Commercial Analgesics or Unknowns steps were omitted since we included an unknown on our second plate.
Observations and Data:
Total TLC development time was 50 minutes.
Table 1: TLC Data for Standard Analgesics, Reference Mix & Unknown Components* Standard Substance | Distance Spot Travels (cm) | Distance Solvent Front Travels (cm) | Fluorescence? | I2 Staining Appearance | Acetaminophen | 48 | 150 | No | Dark Yellow | Aspirin | 86 | 150 | No | Not Significant | Caffeine | 14 | 150 | No | Not Significant | Ibuprofen | 92 | 148 | No | Not Significant | Salicylamide | 81 | 148 | Yes |